Patents by Inventor Frederick David

Frederick David has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antimicrobial preservatives to achieve multi-dose formulation using beta-cyclodextrins for liquid dosage forms
    Patent number: 8183230
    Abstract: The present invention is directed to pharmaceutical compositions containing a therapeutically effective amount of an Active Pharmaceutical Ingredient (“API”), a pharmaceutically acceptable cyclodextrin and a pharmaceutically acceptable preservative. The invention is also directed to pharmaceutical compositions of the compounds of Formula (I) wherein R2 is selected from the group consisting of methyl, ethyl, isopropyl, sec-butyl and tert-butyl and a pharmaceutically acceptable cyclodextrin and preservative. Formula (I): In particular, the invention is directed to pharmaceutical compositions of the compound of Formula 1a, and a pharmaceutically acceptable cyclodextrin and a preservative.
    Type: Grant
    Filed: January 17, 2005
    Date of Patent: May 22, 2012
    Assignees: Pfizer Inc., Pfizer Products Inc.
    Inventors: Roger C. Adami, Frederick David, Julia Ann Wood
  • Use of NK-3 Receptor Antagonists for the Treatment of Nausea and Vomiting
    Publication number: 20090163544
    Abstract: This invention relates to the treatment or prevention of nausea and/or vomiting by the administration of a NK-3 receptor antagonist.
    Type: Application
    Filed: March 31, 2006
    Publication date: June 25, 2009
    Inventors: Michael Rigby, Frederick David
  • Antimicrobial preservatives to achieve multi-dose formulation using beta-cyclodextrins for liquid dosage forms
    Publication number: 20070155697
    Abstract: The present invention is directed to pharmaceutical compositions containing a therapeutically effective amount of an Active Pharmaceutical Ingredient (“API”), a pharmaceutically acceptable cyclodextrin and a pharmaceutically acceptable preservative. The invention is also directed to pharmaceutical compositions of the compounds of Formula (I) wherein R2 is selected from the group consisting of methyl, ethyl, isopropyl, sec-butyl and tert-butyl and a pharmaceutically acceptable cyclodextrin and preservative. Formula (I): In particular, the invention is directed to pharmaceutical compositions of the compound of Formula 1a, and a pharmaceutically acceptable cyclodextrin and a preservative.
    Type: Application
    Filed: January 17, 2005
    Publication date: July 5, 2007
    Inventors: Roger Adami, Frederick David, Julia Wood